ClinicalTrials.govpublic full text
Monoclonal Antibody ABX-EGF in Treating Patients With Renal (Kidney), Prostate, Pancreatic, Non-Small Cell Lung, Colon or Rectal, Esophageal, or Gastroesophageal Junction Cancer
colorectal cancer, esophageal cancer, kidney cancer, lung cancer, pancreatic cancer, prostate cancer, recurrent renal cell cancer, recurrent prostate cancer, recurrent colon cancer, recurrent rectal cancer, recurrent non-small cell lung cancer, recurrent pancreatic cancer
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 868164
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.